Claims for Patent: 7,662,125

Summary for Patent: 7,662,125

Title:	Devices and methods for delivering active agents to target sites
Abstract:	The subject invention provides novel, inexpensive, and highly effective methods and devices for convenient and effective wound irrigation. In one embodiment the subject invention provides a discharge means for a reservoir housing containing irrigation solution wherein the discharge means has one or more specifically designed nozzles through which a sufficient volume of the irrigation solution can pass at an appropriate pressure.
Inventor(s):	Rucinski; Paul J. (Gainesville, FL)
Assignee:	Innovation Technologies, Inc. (Gainesville, FL)
Application Number:	11/960,390
Patent Claims:	1. A method for irrigating a wound, said method comprising the following steps: (a) providing a sterile wound-irrigation solution in a wound irrigation device comprising a reservoir housing, wherein said wound irrigation device comprises a discharge means that directs a pressurized stream of said wound irrigation solution when said reservoir housing is pressurized, wherein said reservoir housing is made of a resilient compressible material and wherein said discharge means comprises a plurality of ports through which said sterile wound irrigation solution passes when the reservoir housing is compressed, and wherein said wound irrigation solution is sterile water with an active agent that consists of a chlorhexidine, at a concentration of less than 1%; (b) directing the discharge means and reservoir housing so as to discharge the wound-irrigation solution toward said wound; and (c) discharging said wound-irrigation solution from said reservoir housing and through said ports to produce a dispersed stream of said wound irrigation solution directed at said wound, wherein said dispersed stream is applied with sufficient force to dislodge contaminants, thereby effectively irrigating said wound. 2. The method, according to claim 1, wherein said wound-irrigation solution is discharged from said ports at a pressure between about 4 PSI and about 20 PSI. 3. The method, according to claim 1, wherein from 250 ml to 750 ml of wound irrigation solution is applied to said wound. 4. The method, according to claim 1, wherein said device further comprises a backsplash shield. 5. The method, according to claim 1, further comprising rinsing the wound within 5 minutes with a wound irrigation solution that does not contain chlorhexidine. 6. The method, according to claim 1, used to treat a wound in the skin of a human. 7. The method, according to claim 1, wherein the chlorhexidine is at a concentration of 0.05% or less. 8. The method according to claim 1, wherein the chlorhexidine is in the form of chlorhexidine gluconate. 9. The method, according to claim 1, wherein the pH of the irrigation solution is between pH 5.5 and pH 7.0. 10. The method, according to claim 1, having ports that comprise shaped nozzles wherein the inlet to the nozzle is rounded and is larger than the outlet. 11. The method, according to claim 1, wherein said wound irrigation fluid consists of sterile water and chlorhexidine at a concentration of about 0.02% to 0.05%. 12. The method, according to claim 1, wherein said wound irrigation fluid consists of sterile water and chlorhexidine at a concentration of about 0.05%. 13. The method, according to claim 5, wherein the wound is rinsed with saline. 14. The method, according to claim 1 wherein the wound irrigation solution consists of an aqueous solution of chlorhexidine wherein the chlorhexidine is at a concentration of less than 1%. 15. The method, according to claim 14, wherein the chlorhexidine is at a concentration of about 0.05%. 16. The method, according to claim 1, used to kill MRSA. 17. The method, according to claim 6, wherein the wound is selected from the group consisting of cuts, scrapes, punctures and abrasions. 18. A method for irrigating a wound, said method comprising the following steps: (a) providing a sterile wound-irrigation solution in a wound irrigation device comprising a reservoir housing, wherein said wound irrigation device comprises a discharge means that directs a pressurized stream of said wound irrigation solution when said reservoir housing is pressurized, and wherein said wound irrigation solution is sterile water with an active agent that consists of a chlorhexidine, at a concentration of less than 1%; (b) directing the discharge means and reservoir housing so as to discharge the wound-irrigation solution toward said wound; and (c) discharging a stream of said wound-irrigation solution from said reservoir housing and through said discharge means directed at said wound. 19. The method, according to claim 18, wherein said wound-irrigation solution is discharged at a pressure between about 4 PSI and about 20 PSI. 20. The method, according to claim 18, wherein from 250 ml to 750 ml of wound irrigation solution is applied to said wound. 21. The method, according to claim 18, wherein said device further comprises a backsplash shield. 22. The method, according to claim 18, further comprising rinsing the wound within 5 minutes with a wound irrigation solution that does not contain chlorhexidine. 23. The method, according to claim 18, used to treat a wound in the skin of a human. 24. The method, according to claim 18, wherein the chlorhexidine is at a concentration of 0.05% or less. 25. The method, according to claim 18, wherein the chlorhexidine is in the form of chlorhexidine gluconate. 26. The method, according to claim 18, wherein said wound irrigation fluid consists of sterile water and chlorhexidine at a concentration of about 0.02% to 0.05%. 27. The method, according to claim 18, wherein said wound irrigation fluid consists of sterile water and chlorhexidine at a concentration of about 0.05%. 28. The method, according to claim 22, wherein the wound is rinsed with saline. 29. The method, according to claim 18, wherein the wound irrigation solution consists of an aqueous solution of chlorhexidine wherein the chlorhexidine is at a concentration of less than 1%. 30. The method, according to claim 29, wherein the chlorhexidine is at a concentration of about 0.05%. 31. The method, according to claim 18, used to kill MRSA. 32. The method, according to claim 23, wherein the wound is a surgical wound.

Details for Patent 7,662,125

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2026-12-19